Laboratorios Rovi : CMD highlights

IBERIAN DAILY 26 MARCH (ANÁLISIS BANCO SABADELL)

NEWS SUMMARY: ENDESA, NATURGY, OHLA, ROVI, TALGO. IBEX close to 13,500 Boosted by the good start to the week in the US and with no new scares on the tariff front, European stock markets rallied, with the IBEX once again leading the way. In the STOXX 600, all the sectors except Retail, Food and Chemicals posted gains, led by Banks and Travel & Leisure. On the macro side, in Germany March’s IFO rose in line with expectations, with better performance in the expectations component. In the US, March’s consumer confidence fell more than expected, with the expectations index at a 12-year low. Febru...

MAPFRE: MENSAJES DE LA CONFERENCE CALL RDOS. 1T’25 (ANÁLISIS BANCO SABADELL)

Mensajes confiados, de los que destacamos:  Pese a la incertidumbre macroeconómica por la guerra comercial, MAP reitera que el carácter anticíclico del seguro

MAPFRE: 1Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

1Q'25 vs. 1Q'24 Results Premiums: € 8.584 Bn (+5.4% vs. +1.5% BS(e) and +0.8% consensus); Operating Result: € 617.4 M (+13.7% vs. -1.1% BS(e) and +3.1% consensus); Net Profit: € 275.9 M (+27.6% vs. -1.5% BS(e) and +7.3% consensus).

MAPFRE: RDOS. 1T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 1T'25 vs 1T'24: Primas: 8.584 M euros (+5,4% vs +1,5% BS(e) y +0,8% consenso); Rdo. Operativo: 617,4 M euros (+13,7% vs -1,1% BS(e) y +3,1% consenso); BDI: 275,9 M euros (+27,6% vs -1,5% BS(e) y +7,3% consenso);